Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments ...

In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate's levels had jumped. Previously in a normal range, LaFrate's PSA was now above 6 ng/mL, indicating an elevated ...

Can clinico-genomic characterization reveal more aggressive prostate cancer among older patients with lower Gleason grade groups? This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

A longitudinal study that tracked men over 10 years aims to provide patients with more information about their options following a diagnosis of prostate cancer. The study published Tuesday in the ...

Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. Prostate cancer: 1 in 8 men in the United States will be ...

If you or a loved one has been diagnosed with prostate cancer, you’re not alone—and you don’t have to wait long to take the next step. Whether you’re newly diagnosed, moving from active surveillance ...